Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19.

MLA

Núñez-Muñoz, Leandro, et al. “Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19.” Vaccines, vol. 9, no. 8, Aug. 2021, p. 928. EBSCOhost, https://doi.org/10.3390/vaccines9080928.

APA

Núñez-Muñoz, L., Marcelino-Pérez, G., Calderón-Pérez, B., Pérez-Saldívar, M., Acosta-Virgen, K., González-Conchillos, H., Vargas-Hernández, B., Olivares-Martínez, A., Ruiz-Medrano, R., Roa-Velázquez, D., Morales-Ríos, E., Ramos-Flores, J., Torres-Franco, G., Peláez-González, D., Fernández-Hernández, J., Espinosa-Cantellano, M., Tapia-Sidas, D., Ramírez-Pool, J. A., Padilla-Viveros, A., & Xoconostle-Cázares, B. (2021). Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19. Vaccines, 9(8), 928. https://doi.org/10.3390/vaccines9080928

Chicago

Núñez-Muñoz, Leandro, Gabriel Marcelino-Pérez, Berenice Calderón-Pérez, Miriam Pérez-Saldívar, Karla Acosta-Virgen, Hugo González-Conchillos, Brenda Vargas-Hernández, et al. 2021. “Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19.” Vaccines 9 (8): 928. doi:10.3390/vaccines9080928.